Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06662708

Artificial Intelligence Models for Precision Prediction and Treatment of Prostate Cancer

Accurate Prediction and Treatment of Prostate Cancer by Artificial Intelligence Model-based Whole Slide Images and MRIs

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Shao Pengfei · Academic / Other
Sex
Male
Age
30 Years
Healthy volunteers
Accepted

Summary

The aim of this clinical trial is whether artificial intelligence models can be used for accurate clinical preoperative diagnosis and postoperative diagnosis of pathological findings, and will also measure the accuracy of the predictions made by the artificial intelligence models.The main target questions addressed by the model building are: 1. whether the AI model can learn from preoperative MRI and postoperative Whole Slide Images so as to accurately predict information such as benignness or malignancy, aggressiveness, grading, subtypes, genes, etc. for participants suspected of having prostate cancer preoperatively/puncturally. 2. whether the AI model is capable of learning postoperative macropathology slides to enable outcome diagnosis of surgical pathology slides in new participants. Participants will: 1. complete an MRI examination and have their MRI images analysed by the established AI model to make an accurate diagnosis of them. 2. Based on the diagnosis, if prostate cancer is predicted, they will undergo radical prostate cancer surgery and refine their surgical pathology.

Detailed description

Based on artificial intelligence technology, the prediction model is built by outlining the quantitative mapping correlation between annotated prostate cancer Whole Slide Images and MRI, and clarifying the common features. Firstly, the model can accurately diagnose the radical pathology of prostate cancer, which can be exempted from immunohistochemistry to obtain detailed pathological information; secondly, the established AI prediction model can accurately diagnose the benign/malignant, invasiveness, grade and subtype of prostate cancer by predicting the participant's MRI images before surgery or puncture, so that a personalised treatment plan can be formulated for the patient before operation or puncture. Finally, based on AI technology, the model learns from the MRI images and performs 3D reconstruction of the prostate and lesions before surgery/puncture, thus clarifying the exact location of the lesions and guiding puncture or surgical treatment.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTAccurate Prediction Artificial Intelligence ModelsDiagnostic Test: Accurate Prediction Artificial Intelligence Models Post-operative pathology, precise pre-operative diagnosis (including benign and malignant, invasive, grading, subtypes) or 3D lesion modelling will be predicted based on the AI predictive model in response to the information provided

Timeline

Start date
2024-12-01
Primary completion
2030-01-01
Completion
2030-12-31
First posted
2024-10-29
Last updated
2024-10-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06662708. Inclusion in this directory is not an endorsement.